This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Clorox (CLX) Readies for Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Clorox's (CLX) fourth-quarter fiscal 2022 results are likely to reflect gains from the IGNITE strategy and pricing actions, whereas elevated cost concerns are likely to have affected profits.
Post Holdings (POST) Queued for Q3 Earnings: Things to Note
by Zacks Equity Research
Post Holdings' (POST) Q3 performance is likely to reflect adverse impacts from higher raw material, freight and manufacturing costs. Also, supply chain disruptions might be a concern.
Medifast (MED) Readies for Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Medifast's (MED) second-quarter 2022 results are likely to reflect gains from its OPTAVIA lifestyle solution and coaching support system, while escalated costs might have been a concern.
What's in Store for Service Corporation (SCI) in Q2 Earnings?
by Zacks Equity Research
Service Corporation's (SCI) second-quarter 2022 results are likely to reflect higher funeral revenues, whereas elevated costs might have been a deterrent.
Factors Likely to Decide Carter's (CRI) Fate in Q2 Earnings
by Zacks Equity Research
Carter's (CRI) second-quarter results are likely to reflect the impacts of weak retail sales, high freight costs and supply chain issues. However, online strength and improved price realization act as upsides.
Kellogg (K) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
by Zacks Equity Research
Kellogg (K) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Factors to Influence Procter & Gamble (PG) in Q4 Earnings
by Zacks Equity Research
Procter & Gamble's (PG) Q4 results are expected to reflect gains from strong demand for cleaning products and improved productivity, amid rising input costs and supply- chain woes.
Factors to Decide the Fate of Colgate (CL) in Q2 Earnings
by Zacks Equity Research
Colgate's (CL) Q2 results are expected to reflect gains from strong consumer demand, innovation, premiumization, digital growth and robust pricing actions amid rising raw material and logistic costs.
Here's How FEMSA (FMX) is Poised Just Ahead of Q2 Earnings
by Zacks Equity Research
FEMSA's (FMX) Q2 results are expected to reflect gains from strength across businesses, owing to effective growth strategies and robust demand across markets amid supply-chain and inflation woes.
Mondelez (MDLZ) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Mondelez (MDLZ) delivered earnings and revenue surprises of 4.69% and 6.85%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Kellogg (K) Could Beat Earnings Estimates Again
by Zacks Equity Research
Kellogg (K) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Kellogg (K) Stock Up 7% in 3 Months: Will the Momentum Last?
by Zacks Equity Research
Kellogg Company (K) has been benefiting from its brands and solid performance in the Europe, Middle East and Africa region. However, supply-chain hurdles are a concern.
3 Stocks up Double-Digit Percentages in 2022
by Derek Lewis
There have been a few bright spots in this volatility-packed market, and believe it or not, there are stocks out there up double-digit percentages year-to-date.
Company News for Jun 22, 2022
by Zacks Equity Research
Companies in The News Are: K, SAVE, JBLU, LEN, AMD
Kellogg (K) Unveils Major Step Toward Portfolio Enhancement
by Zacks Equity Research
Kellogg Company (K) to divide its North American cereal and plant-based food businesses, leading to three independent companies, including Global Snacking Co., North America Cereal Co. and Plant Co.
Kellogg (K) Benefits From EMEA Region, High Costs a Worry
by Zacks Equity Research
Kellogg Company (K) has been benefiting from strength in the EMEA region and its robust snacks business, especially Pringles. However, cost headwinds prevail.
Best Defensive Stocks to Buy
by David Bartosiak
With volatility spiking and stocks falling, these are some great stocks to buy to save your portfolio.
Kellogg's (K) Q1 Earnings Top Estimates, Organic Sales View Up
by Zacks Equity Research
Kellogg Company's (K) first-quarter 2022 results reflect higher sales, thanks to strength in snacks and solid price/mix. Earnings were hurt by increased cost inflation and other business hurdles.
Kellogg (K) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Kellogg (K) delivered earnings and revenue surprises of 20.88% and 2.51%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
The J.M. Smucker (SJM) Gains on Demand Amid Cost Hurdles
by Zacks Equity Research
The J.M. Smucker (SJM) has been gaining on the revival in away from home demand and its focus on core priorities, while cost headwinds have been a concern.
Factors to Note as Kellogg (K) Queues Up for Q1 Earnings
by Zacks Equity Research
Kellogg's (K) first-quarter results are likely to reflect the adverse impacts of cost inflation and supply-chain hurdles, whereas strength in the EMEA region has been an upside.
Earnings Preview: Kellogg (K) Q1 Earnings Expected to Decline
by Zacks Equity Research
Kellogg (K) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Kimberly-Clark (KMB) Queued for Q1 Earnings: Things to Note
by Zacks Equity Research
Kimberly-Clark's (KMB) first-quarter 2022 performance is likely to reflect higher input cost inflation and supply-chain disruptions. Nevertheless, cost-saving efforts bode well.
What's in the Offing for Philip Morris (PM) in Q1 Earnings?
by Zacks Equity Research
Philip Morris' (PM) first-quarter 2022 results are likely to reflect certain hurdles related to the pandemic, such as soft duty-free sales in Asia. However, strong pricing has been an upside.
Why Kellogg (K) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Kellogg (K) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.